N-(2-chloroethylidene)hydroxylamine

We are N-(2-chloroethylidene)hydroxylamine CAS:51451-05-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 51451-05-9
Product Name: N-(2-chloroethylidene)hydroxylamine
Other Name:
N-(2-chloroethylidene)hydroxylamine
Chloroacetaldehyde oxime
 
Molecular Formula: C2H4ClNO
Molecular Weight: 93.51230
Exact Mass: 92.99810
PSA: 32.59000
LogP: 0.68520
 
Specification
Assay: ≥99.0%
Loss on drying: ≤0.5%
 
Application
Intermediates of Alanycarb CAS: 83130-01-2.
Intermediates of Thiodicarb CAS: 59669-26-0.
Intermediates of Methylthioacetaldoxime CAS: 1053-36-7.
Be used as pesticide intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

N-(2-chloroethylidene)hydroxylamine


Related News: CMO services mainly involve four stages: pre-clinical research, clinical trials, sales of patented drugs after listing, and sales of original drug products after patents expire. Its advantages are: lower cost, guaranteed quality, good capacity flexibility, and favorable process Promotion.3-amino-4-cyclobutyl-2-oxobutanamide,hydrochloride Retrogenix’s extensive library of human proteins make it uniquely placed for assessing candidate antibodies for target binding.4-Methyl-3-nitrophenol We are pleased to work with Inceptua, given their strong record of administering such programs successfully.”26759-46-6 It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance.Catalent, a global leader in clinical supply services, recently announced the launch of its new CTSuccessTM clinical trial planning service, designed to support trial sponsors with earlier, more proactive and robust clinical supply chain planning, and reduce the risk of delays and budget overspend common to clinical trials as they progress.

Related Products
Product Name
4-tert-Butylphenylboronic acid View Details
5-Trifluoromethyl-1H-indole-2-carboxylic acid View Details
2,5-Dichlorophenol View Details
axitinib Cas:319460-85-0 manufacturer 1,3-dimethyladamantane manufacturer 2,2′-Dibromodiethyl ether manufacturer Z-β-ALA-OSU manufacturer Poly(dimethylsiloxane) hydride terminated manufacturer